Varma Mutual Pension Insurance Co Buys 9,100 Shares of GE HealthCare Technologies Inc. $GEHC

Varma Mutual Pension Insurance Co increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 9.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 110,400 shares of the company’s stock after acquiring an additional 9,100 shares during the quarter. Varma Mutual Pension Insurance Co’s holdings in GE HealthCare Technologies were worth $8,291,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Dodge & Cox increased its holdings in shares of GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. Norges Bank bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $468,120,000. Holocene Advisors LP raised its holdings in shares of GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after acquiring an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at about $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new position in shares of GE HealthCare Technologies during the second quarter worth about $58,388,000. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on GEHC. Evercore raised their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. BTIG Research increased their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Finally, Jefferies Financial Group raised their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $92.50.

Get Our Latest Stock Analysis on GE HealthCare Technologies

GE HealthCare Technologies Stock Up 2.1%

Shares of GE HealthCare Technologies stock opened at $80.34 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $93.26. The company has a market cap of $36.61 billion, a P/E ratio of 17.62, a PEG ratio of 1.73 and a beta of 1.08. The company’s fifty day simple moving average is $82.44 and its two-hundred day simple moving average is $77.62.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the previous year, the company earned $1.45 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.